SCHEMBL2222211

SCHEMBL2222211

CCOc1ccc(S(=O)(=O)c2c[nH]c3cc(F)ccc23)cc1NC1CCN(C)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.47
TDO2 P48775 6/20 0.42
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP3A4 P08684 5/20 0.41
DRD2 P14416 3/20 0.41
SLC6A2 P23975 2/20 0.41
HTR2A P28223 2/20 0.41
HTR2C P28335 2/20 0.41
HTR7 P34969 2/20 0.41
HRH1 P35367 2/20 0.41
ADRA1B P35368 2/20 0.41
SLC6A3 Q01959 2/20 0.41
HTR6 P50406 1/20 0.39
CYP2D6 P10635 3/20 0.39
SLC6A4 P31645 2/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2223020 0.93 KCNH2 (0.49) KCNH2KDM4ELMNAHTTSMN1; SMN2
SCHEMBL2222150 0.91 KCNH2 (0.58) KCNH2TDO2LMNAHTTSMN1; SMN2
SCHEMBL2222673 0.89 CYP3A4 (0.43) KCNH2KDM4ELMNAHTTSMN1; SMN2
SCHEMBL2272640 0.89 MEN1 (0.46) KCNH2KDM4ESMN1; SMN2CYP3A4DRD2
SCHEMBL2226483 0.86 KCNH2 (0.47) KCNH2TDO2CYP3A4DRD2SLC6A2
SCHEMBL2266345 0.86 KCNH2 (0.43) KCNH2TDO2CYP3A4DRD2HTR6
SCHEMBL2224088 0.85 KCNH2 (0.43) KCNH2TDO2CYP3A4DRD2SLC6A2
SCHEMBL2221872 0.83 KCNH2 (0.42) KCNH2TDO2CYP3A4HTR6CDK2
SCHEMBL2222402 0.83 KCNH2 (0.60) KCNH2LMNAHTTSMN1; SMN2CYP3A4
SCHEMBL2221770 0.81 KCNH2 (0.49) KCNH2KDM4ELMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP claimed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO claimed
US-9018231-B2 Sulfone compounds as 5-HT6 receptor ligands SUVEN LIFE SCIENCES LIMITED (IN) 2015-04-28 US disclosed
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2013-01-03 US disclosed
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP disclosed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS HTR6, HTR5A, HTR1A KCNH2 2828/4885TDO2 229/4885KDM4E 4396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.